Matches in Wikidata for { <http://www.wikidata.org/entity/Q63812672> ?p ?o ?g. }
Showing items 1 to 38 of
38
with 100 items per page.
- Q63812672 description "clinical trial" @default.
- Q63812672 description "ensayu clínicu" @default.
- Q63812672 description "klinisch onderzoek" @default.
- Q63812672 description "клінічне випробування" @default.
- Q63812672 name "A Study of Atezolizumab (an Engineered Anti-Programmed Death-Ligand 1 [PDL1] Antibody) to Evaluate Safety, Tolerability and Pharmacokinetics in Participants With Locally Advanced or Metastatic Solid Tumors" @default.
- Q63812672 type Item @default.
- Q63812672 label "A Study of Atezolizumab (an Engineered Anti-Programmed Death-Ligand 1 [PDL1] Antibody) to Evaluate Safety, Tolerability and Pharmacokinetics in Participants With Locally Advanced or Metastatic Solid Tumors" @default.
- Q63812672 prefLabel "A Study of Atezolizumab (an Engineered Anti-Programmed Death-Ligand 1 [PDL1] Antibody) to Evaluate Safety, Tolerability and Pharmacokinetics in Participants With Locally Advanced or Metastatic Solid Tumors" @default.
- Q63812672 P1132 Q63812672-E774DFA6-0310-491A-8040-0278C95ED1F5 @default.
- Q63812672 P1476 Q63812672-58D8872B-A8E8-4C95-ACBA-02C77B5C86AA @default.
- Q63812672 P17 Q63812672-256468DC-F918-4043-82DC-6C6A4386E505 @default.
- Q63812672 P17 Q63812672-2F4D7B67-DC35-49A3-99A7-5CC7B0FDCD12 @default.
- Q63812672 P17 Q63812672-BD61CE8D-31F1-4D5F-BB98-59DCD826CFA2 @default.
- Q63812672 P2899 Q63812672-6D73B27C-C063-4D83-8C26-649FC72CBFCC @default.
- Q63812672 P3098 Q63812672-9F77E24B-095C-4F6F-83D4-FADF4E02E74E @default.
- Q63812672 P31 Q63812672-E0074673-FCF7-4A14-8181-CEBC00A249F6 @default.
- Q63812672 P580 Q63812672-70F0FAE2-FBE0-4303-8A2E-B4205D13A730 @default.
- Q63812672 P582 Q63812672-FCB17FD2-951F-4DFF-9C80-0DAC5D91690B @default.
- Q63812672 P6099 Q63812672-B02BF6D4-4DA3-4E4E-87F2-55C69D725D71 @default.
- Q63812672 P6153 Q63812672-0FC82A86-C730-40A4-8F93-CB1817DD9299 @default.
- Q63812672 P6153 Q63812672-E59B09BD-EDA1-454E-B1FC-3EA0D8F24892 @default.
- Q63812672 P6153 Q63812672-EC8861DB-443F-4208-A3D2-A5247979F25C @default.
- Q63812672 P8363 Q63812672-0B611C8A-CDC0-4C0E-B4E8-C95DF0A2FD36 @default.
- Q63812672 P1132 "+661" @default.
- Q63812672 P1476 "A Phase I, Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of Atezolizumab (MPDL3280A) Administered Intravenously as a Single Agent to Patients With Locally Advanced or Metastatic Solid Tumors or Hematologic Malignancies" @default.
- Q63812672 P17 Q142 @default.
- Q63812672 P17 Q145 @default.
- Q63812672 P17 Q29 @default.
- Q63812672 P2899 "+18" @default.
- Q63812672 P3098 "NCT01375842" @default.
- Q63812672 P31 Q30612 @default.
- Q63812672 P580 "2011-06-21T00:00:00Z" @default.
- Q63812672 P582 "2018-09-30T00:00:00Z" @default.
- Q63812672 P6099 Q5452194 @default.
- Q63812672 P6153 Q2944832 @default.
- Q63812672 P6153 Q30270654 @default.
- Q63812672 P6153 Q500606 @default.
- Q63812672 P8363 Q78089383 @default.